Found 0 matching trials
A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
PHASE2Purpose: This study will assess the safety and efficacy of Endostar combine...
Location
Nanjing General Hospital of Nanjing Military Command
The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients
PHASE3The purpose of the present study was to prospectively evaluate the efficacy...
Location
Multiple Locations
Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous Melanoma
PHASE2The goal of this clinical trial is to evaluate the efficacy and safety of E...
Location
Fudan University Shanghai Cancer Center
PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based Chemotherapy
PHASE1This trial is an open-label, randomized, multicenter study to explore Endos...
Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer
PHASE2The purpose of this study is to investigate whether endostar (recombinant h...
Location
Department of GI Oncology, Peking University, School of Oncology
Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer
PHASE2The purpose of this study is to evaluate the efficacy and tolerability of t...
Location
Fudan University Cancer Hospital
Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer
PHASE2This phase β
‘ study was designed to evaluate the efficacy and safety of endo...
Location
Sun Yat-sen University Cancer Center
Camrelizumab Combined With Endostar for First-line Treatment in Subjects With Advanced Squamous NSCLC
PHASE2This study is a single-arm, prospective, multi-center clinical trial. desig...
Location
Beijing Cancer Hospital
Endostar Combined With Chemotherapy for Stage β
£ Soft Tissue Sarcoma
PHASE2This is a randomized, double-blind, placebo-controlled (2: 1), multicenter ...
Location
Tianjin Medical University Cancer Hospital & Institute
Endostar Combined With IP Second-line Treatment of Advanced Esophageal Squamous Cell Carcinomas
PHASE2The aim of this study is to explore whether endostar combined with IP as tr...
Location
Cancer hospital Fudan University